1. US Department of Health and Human Services. Guidance for industry: Patient-reported outcome measures: Use in medical product development to support labeling claims. 2009. Available from:
http://www.fda.gov/downloads/Drugs/GuidanceCompliance RegulatoryInformation/Guidances/UCM193282.pdf
.
2. European Medicines Agency. Reflection paper on the regulatory guidance for use of health-related quality of life (HRQOL) measures in the evaluation of medicinal products. 2005. Available from: www.
ema.europa.eu
/docs/en_GB/document_library/Scientific_guideline/ 2009/09/WC500003637.pdf.
3. US Department of Health and Human Services. Guidance for industry and FDA Staff: Qualification Process for Drug Development Tools. 2014. Available from:
http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM230597.pdf
.
4. Engelberg Center for Health Care Reform at Brookings. Enhancing the Development and Use of Patient-Reported Outcomes in Drug Development. 2014. Available from:
https://www.brookings.edu/events/enhancing-the-development-and-use-of-patient-reported-outcomes-in-drug-development/
5. Gnanasakthy, A., Mordin, M., Clark, M., DeMuro, C., Fehnel, S., & Copley-Merriman, C. (2012). A review of patient-reported outcome labels in the United States: 2006 to 2010. Value Health, 15, 437–442.